Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Itamar MedicalEloxx PharmaceuticalsImricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIBEyepoint PharmaceuticalsSpectral Medical
SymbolNASDAQ:ITMROTCMKTS:ELOXASX:IMRNASDAQ:EYPTTSE:EDT
Price Information
Current Price$14.49$2.20A$0.90$0.81C$0.52
52 Week RangeBuyBuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyN/A
Consensus Price Target$19.25$11.00N/A$3.63N/A
% Upside from Price Target32.85% upside400.00% upsideN/A347.59% upsideN/A
Trade Information
Market Cap$134.07 million$82.64 million$94.29 million$104.78 millionC$115.17 million
BetaN/AN/AN/A1.72N/A
Average Volume42,142163,583N/A768,96883,253
Sales & Book Value
Annual Revenue$31.26 millionN/A$639,704.00$20.36 millionC$2.87 million
Price / Sales4.45N/A147.404.9640.94
CashflowN/AN/AA$0.06 per shareN/AC$0.01 per share
Price / CashN/AN/A14.63N/A81.67
Book ValueN/AN/AA$0.08 per share$0.08 per shareC$0.01 per share
Price / BookN/A11.8410.1252.00
Profitability
Net IncomeN/AN/AN/A$-56,790,000.00N/A
EPS($0.40)N/AA($0.22)($0.48)C($0.02)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-278.89%N/A
Return on Equity (ROE)N/AN/AN/A-285.39%N/A
Return on Assets (ROA)N/AN/AN/A-63.49%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A28.04%6.02%32.92%
Current RatioN/AN/A4.78%3.62%2.46%
Quick RatioN/AN/A3.73%3.44%2.06%
Ownership Information
Institutional Ownership Percentage4.41%N/AN/A50.26%N/A
Insider Ownership PercentageN/A44.03%N/A41.29%N/A
Miscellaneous
Employees153N/AN/A5518
Shares Outstanding9.59 million40.13 million104.77 million124.74 million225.82 million
Next Earnings Date6/2/2020 (Estimated)N/AN/A6/3/2020 (Estimated)5/14/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel